India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...
from NDTV News - Special https://ift.tt/3bqUqQ1
via IFTTT
No comments:
Post a Comment